British journal of biomedical science

VSL#3® probiotic helps reduce fatigue in long COVID patients: findings from a controlled trial

Updated

Abstract

Evaluation of the probiotic formulation VSL#3® in patients with long COVID suggests potential benefits.

  • Long COVID is often linked to ongoing fatigue and reduced quality of life.
  • Dysregulation of gut bacteria and immune responses may play a role in the persistence of symptoms.
  • The impact of VSL#3® on long COVID symptoms is being assessed.
  • Preliminary findings could indicate that this probiotic formulation may help improve patient outcomes.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free